Prospects for control of herpes simplex virus disease through immunization. (Q33866424)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Prospects for control of herpes simplex virus disease through immunization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

Anthony L. Cunningham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Adrian Mindel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Stanberry LR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Scott LL

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Spruance SL

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Aoki FY

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Lacey CJ

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

Clinical Infectious Diseases

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

549-566

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10722443%20AND%20SRC:MED&resulttype=core&format=json

Herpes simplex virus vaccines as immunotherapeutic agents.

5 November 2019

cites work

1 reference

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

21 January 2018

1 reference

21 January 2018

Herpes simplex viruses

1 reference

Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections

21 January 2018

1 reference

Recurrent herpes simplex virus type 1 infection precipitated by the impaired production of interleukin-2, alpha-interferon, and cell-mediated cytotoxicity

21 January 2018

1 reference

Th1/Th2-like immunity and resistance to herpes simplex labialis.

21 January 2018

1 reference

In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production?

21 January 2018

1 reference

Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

21 January 2018

1 reference

Role of keratinocytes in human recurrent herpetic lesions. Ability to present herpes simplex virus antigen and act as targets for T lymphocyte cytotoxicity in vitro

21 January 2018

1 reference

Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes

21 January 2018

1 reference

Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes

21 January 2018

1 reference

Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir

21 January 2018

1 reference

Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract

21 January 2018

1 reference

Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.

21 January 2018

1 reference

Experimental ulcerative herpetic keratitis. I. Systemic immune responses and resistance to corneal infection

21 January 2018

1 reference

Herpes Simplex Virus Type 2 and Acute Aseptic Meningitis: Clinical Features of Cases with Isolation of Herpes Simplex Virus from Cerebrospinal Fluids

21 January 2018

1 reference

Herpes simplex virus proctitis in homosexual men. Clinical, sigmoidoscopic, and histopathological features

21 January 2018

1 reference

Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men

21 January 2018

1 reference

Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type

21 January 2018

1 reference

Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment

21 January 2018

1 reference

Virologic characteristics of subclinical and symptomatic genital herpes infections

21 January 2018

1 reference

Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

21 January 2018

1 reference

Asymptomatic virus shedding in men with genital herpes infection

21 January 2018

1 reference

A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States

21 January 2018

1 reference

Herpes simplex virus type 2 in the United States, 1976 to 1994.

21 January 2018

1 reference

Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations

21 January 2018

1 reference

Herpes simplex type 2 infection in a cohort aged 21 years

21 January 2018

1 reference

Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents

21 January 2018

1 reference

The natural history of recurrent herpes simplex labialis: implications for antiviral therapy

21 January 2018

1 reference

Ocular disease pattern induced by herpes simplex virus is genetically determined by a specific region of viral DNA

21 January 2018

1 reference

Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis

21 January 2018

1 reference

A clinical study for the control of facial mucocutaneous herpes virus infections. I. Characterization of natural history in a professional school population

21 January 2018

1 reference

A retrospective study of recurrent herpes labialis (RHL) in a professional population, 1958–1971

21 January 2018

1 reference

Recurrent herpes in the rabbit and man.

21 January 2018

1 reference

Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations

21 January 2018

1 reference

Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response.

21 January 2018

1 reference

Herpes simplex virus-2 infection. An emerging disease?

21 January 2018

1 reference

Neonatal herpes simplex virus infection in the British Isles

21 January 2018

1 reference

Intrauterine infection with herpes simplex virus. Resultant congenital malformations

21 January 2018

1 reference

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

21 January 2018

1 reference

The management of pregnancies complicated by genital infections with herpes simplex virus

21 January 2018

1 reference

The acquisition of herpes simplex virus during pregnancy

21 January 2018

1 reference

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group

21 January 2018

1 reference

Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor

21 January 2018

1 reference

Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs

21 January 2018

1 reference

A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection

21 January 2018

1 reference

Strain specificity of spontaneous and adrenergically induced HSV-1 ocular reactivation in latently infected rabbits

21 January 2018

1 reference

Recurrence phenotypes and establishment of latency following rabbit keratitis produced by multiple herpes simplex virus strains

21 January 2018

1 reference

The characteristic site-specific reactivation phenotypes of HSV-1 and HSV-2 depend upon the latency-associated transcript region

21 January 2018

1 reference

Strain specificity of clinical isolates of herpes simplex virus

21 January 2018

1 reference

Lesions produced by human herpesviruses 1 and 2. Morphologic features in rabbit corneal epithelium

21 January 2018

1 reference

Epidemiological and clinical features of primary herpes simplex virus ocular infection

21 January 2018

1 reference

Spread of Virus and Distribution of Latent Infection Following Ocular Herpes Simplex in the Non-immune and Immune Mouse

21 January 2018

1 reference

Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study

21 January 2018

1 reference

Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients.

21 January 2018

1 reference

Herpes simplex encephalitis. Clinical Assessment

21 January 2018

1 reference

Herpes simplex encephalitis: long term magnetic resonance imaging and neuropsychological profile

21 January 2018

1 reference

Reactivation of herpes simplex virus type 1 in patients with Bell's palsy

21 January 2018

1 reference

Detection of herpes simplex virus DNA in cutaneous lesions of erythema multiforme

21 January 2018

1 reference

Recurrent erythema multiforme: clinical features and treatment in a large series of patients.

21 January 2018

1 reference

Examination of non-involved skin, previously involved skin, and peripheral blood for herpes simplex virus DNA in patients with recurrent herpes-associated erythema multiforme

21 January 2018

1 reference

HLA DQB1*0301 allele is involved in the susceptibility to erythema multiforme

21 January 2018

1 reference

Acyclovir prophylaxis in late pregnancy to prevent neonatal herpes: a cost-effectiveness analysis.

21 January 2018

1 reference

Evaluation of a live attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in guinea pigs

21 January 2018

1 reference

Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection

21 January 2018

1 reference

Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis

21 January 2018

1 reference

Herpesvirus vaccines. Development, controversies, and applications.

21 January 2018

1 reference

Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease

21 January 2018

1 reference

A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

21 January 2018

1 reference

Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes

21 January 2018

1 reference

A recombinant glycoprotein vaccine for herpes simplex virus type 2: safety and immunogenicity [corrected]

21 January 2018

1 reference

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

21 January 2018

1 reference

The recurrence of whooping cough: possible implications for assessment of vaccine efficacy

21 January 2018

1 reference

Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection

21 January 2018

1 reference

Analysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold-adapted vaccine recombinant in which vaccine-associated illness occurred in normal volunteers

21 January 2018

1 reference